Skip to main content

Research News

academics

 

Clinical research courses

  • As India's pharmaceutical companies continue to look for greener pastures for growth, the 70 participants in the two-day IPHEX Africa trade exhibition in the Nigerian commercial capital of Lagos will be aiming to increase their exports to western Africa where they see a significant growth potential.

  • Don't let the high blood pressure that you have been diagnosed with scare you out of your wits. It is not exactly a disease, but only a warning sign that the food you have been eating and the lifestyle you have been leading have clogged your blood vessels and your heart is having to exert extra pressure to keep blood moving through it.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • Paving the way for new depression treatments, researchers have discovered the first-ever connection between vulnerability to depression and a type of brain cells called noradrenergic neurons.

  • A new class of antigens has been identified that may be a contributing factor to type 1 diabetes. Type-1 diabetes is the auto-immune form of diabetes, in which insulin-producing beta cells in the pancreas are destroyed by body's own immune cells, a study finds.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • KemPharm, Inc. announced that the New Drug Application (NDA) for KP201/APAP, its investigational drug candidate for the short-term management of acute pain, has been accepted and granted priority review by the U.S. Food and Drug Administration (FDA).  In addition, the FDA has set a target action date under the Prescription Drug User Fee Act (PDUFA) of June 9, 2016.

Subscribe to Research News